Gomiliximab
Encyclopedia
Gomiliximab is a monoclonal antibody acting as an immunosuppressive drug
for the treatment of allergic asthma. It targets the low affinity IgE receptor (FcεRII or CD23
). The drug is a chimeric antibody from Macaca irus and Homo sapiens.
This drug was developed by IDEC Pharmaceuticals Corporation.
Immunosuppressive drug
Immunosuppressive drugs or immunosuppressive agents are drugs that inhibit or prevent activity of the immune system. They are used in immunosuppressive therapy to:...
for the treatment of allergic asthma. It targets the low affinity IgE receptor (FcεRII or CD23
CD23
CD23, also known as Fc epsilon RII, or FcεRII, is the "low-affinity" receptor for IgE, an antibody isotype involved in allergy and resistance to parasites, and is important in regulation of IgE levels. Unlike many of the antibody receptors, CD23 is a C-type lectin...
). The drug is a chimeric antibody from Macaca irus and Homo sapiens.
This drug was developed by IDEC Pharmaceuticals Corporation.